帕金森病中白质病变的并发症:关于风险因素和表型差异的研究
Zhifei You1, Shuyu Ma2, Hui Xu3
1Department of Neurology, The Affiliated Taizhou People's Hospital of Nanjing Medical University,Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, Jiangsu Province, China.
概括
帕金森病 (PD) 中的白质病变 (WMLs) 与年龄,高血压和疾病严重程度有关. 姿势不稳定步行困难 (PIGD) 现型显示更严重的WML,认知能力下降和更高的同类氨酸水平.
科学领域:
- 神经学 神经学
- 神经成像是一种神经成像.
- 神经退行性疾病 神经退行性疾病
背景情况:
- 白质病变 (WMLs) 在异常性帕金森病 (PD) 中越来越多地观察到.
- 了解WMLs的风险因素和对PD表型的影响至关重要.
研究的目的:
- 在PD患者中确定WMLs的风险因素.
- 为了比较PD表型之间的WML严重程度和相关的临床特征.
主要方法:
- 123名PD患者接受了临床,实验室和MRI评估.
- 通过修改的谢尔斯视觉评级表来评估WMLs.
- 通过MMSE和MoCA评估认知功能.
主要成果:
- 年龄,H-Y阶段和高血压与PD中的WML相关.
- 周心室高强度 (PVH) 在89%的PD患者中存在.
- 与TD表型相比,PIGD表型显示了较高的PVH负担,较低的认知得分 (MMSE,MoCA) 和较高的同类半素.
结论:
- 年龄,H-Y阶段和高血压是PD中WML的独立风险因素.
- WML严重程度与PD表型相关,PVH是最常见的.
- PIGD表型与增加的WMLs,认知障碍和更高的同类半氨酸相关.
相关概念视频
Parkinson's Disease: Overview
499
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
499
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Parkinson's Disease: Treatment
239
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
239
Alzheimer's Disease: Overview
454
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
454
Dementia
107
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
107


